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Abstract
Background and Significance: The World Health Organization (WHO) (2021) reports that 55.4
million people died worldwide in 2019; cardiovascular diseases due to ischemic heart disease
and stroke were the top two leading causes of these deaths. Experts predict that by the year 2030,
more than 22.2 million people will die annually from cardiovascular disease (Ruan et al., 2018).
Noninvasive cardiovascular screening tests, such as the "Pulse4Pulse" screening tool, are a way
to help providers identify patients at high-risk for cardiovascular disease and initiate treatment to
reduce future risk.
Purpose: To increase provider utilization of the "Pulse4Pulse" screening test in a primary care
office. The outcome measures were to increase the number of completed “Pulse4Pulse” tests;
increase the total number of referrals generated from those who completed the “Pulse4Pulse”
test; and, increase the revenue yield from patients completing the test. The goals of this project
were achieved through health education for the providers and written literature for the patients.
Methods: The Plan-Do-Study-Act (PDSA) Cycle was implemented to help guide the project.
The clinical staff's knowledge was assessed through a pre-and post-test following an educational
class. A one-paragraph description attached to the "Pulse4Pulse" questionnaire was distributed to
each eligible patient when first placed in the examination room. Three months of data was
collected. Each month the number of patients eligible for the "Pulse4Pulse" test was recorded as
well as completed tests, total number of referrals, total revenue yielded, and number of referrals
to specialists.
Outcome: Month 3 to month 4 portrayed a 14% increase in completed tests which met the
project goal of 10%. However, the last two months (5 and 6) of the study achieved a 7%
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increase. Lastly, early detection of abnormalities and referrals to specialty care and revenue
generated for the office also increased.
Discussion: This quality improvement project showed the intervention to improve provider and
patient utilization was effective in increasing overall completion rates of the "Pulse4Pulse"
screening test. The findings of this study emphasize the importance of education and
implementation of a cardiovascular screening tool.
Keywords: cardiovascular screening tool, cardiovascular disease, CV screening tool, primary
care, patient outcomes and health outcomes.
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Increasing the Utilization of a Cardiovascular Risk Assessment & Screening Tool through
Education in a Primary Care Setting:
A Quality improvement project
Problem Identification, Development of Clinical Question, and Evidence Review
Background and Significance
The WHO (World Health Organization) (2020) reports that 55.4 million people died
worldwide in 2019; cardiovascular disease (CVD) due to ischemic heart disease and stroke were
the top two leading causes of these deaths. They accounted for approximately 17.9 million or
31% of deaths in the world (WHO, n.d.). Experts predict that by 2030, more than 22.2 million
people will die annually from a CVD (Ruan et al., 2018). Patients at the highest risk for a CVD
are patients with a history of chronic kidney disease, diabetes, excessive alcohol use,
hypertension, hyperlipidemia, obesity, and smoking. Modifiable risk factors account for more
than 70% of all CVD (Sardarinia et al., 2016). Therefore, the burden of cardiovascular disease
can be reduced by disease prevention or early detection (Schwalm et al., 2018). Experts from the
American Diabetes Association (ADA), the American Heart Association/American College of
Cardiology, and the American Neurologic Association believe in-office, noninvasive screening
tests such as the Ankle-Brachial-Index (ABI) (Herraiz-Adillo, Mariana-Herraiz, & PozueloCarrcosa, 2019) and Sudomotor and Autonomic system tests (ADA, 2018) may prevent or detect
early CVD. Hence, the experts recommend providers use noninvasive screening tests in the
primary care setting to improve the care of patients at risk for CVD.
It is expected that all primary care providers remain knowledgeable on standard primary
care practices. This is important when caring for patients who are at risk for cardiovascular
disease. As a result, providers who receive ongoing health education can effectively care for their
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patients and the communities they serve. Health education methods include medical lectures,
posters, leaflets, and videos (Hasanica et al., 2020). Leaflets and posters are widely used by
health organizations to serve as reminders and cues to ensure providers follow treatment and
practice guidelines (Moerenhout et al., 2013).
Patient-provider communication is also crucial in the primary care setting. Office visits
with patients are lengthy and the conversations with patients are complex. Patients may present
with multiple complaints during a visit. Unfortunately, providers have limited time assigned for
each encounter, and this limits what can be addressed in a single visit (Tai-Seale et al., 2007).
Therefore, providers may forget or forego discussing and ordering essential CVD screening tests
in patients at risk for CVD. As a result, some patients never have these important screening tests
completed. This quality improvement (QI) study will examine provider utilization of a
noninvasive cardiovascular screening test, called “Pulse4Pulse”, in a primary care setting.
Description of Local Problem and Organizational Priority
The project took place at a primary care office in Connecticut. This primary care clinic
provides care to patients of all ages. In this clinic, the “Pulse4Pulse” test is used to screen
patients at risk for cardiovascular diseases. Patients who qualify for the test have one or more
conditions listed on the screening questionnaire (refer to Appendix I, titled “Pulse4Pulse”
Screening Questionnaire). The “Pulse4Pulse” screening test consists of three components to
identify asymptomatic disease: autonomic nervous system test, sudomotor test, and an anklebrachial index test. This test can be easily performed the same day of a routine visit and takes
less than 15 minutes to perform. However, use of the “Pulse4Pulse” test in this clinic is low due
to lack of provider time, knowledge, and engagement of how useful this test is in managing
patients at risk for CVDs. Additionally, patients who are offered the screening test do not have it
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completed at the same day visit and fail to schedule a follow-up appointment to have it done at a
later date.
Utilizing the “Pulse4Pulse” test in this primary care office will detect patients at risk for
cardiovascular diseases. Results from this test will improve health outcomes through early
detection, in which modification of current treatment and future adverse events can be prevented.
It is crucial that primary care providers assess patients for cardiovascular diseases to implement
pharmacotherapy, if needed, and counseling regarding lifestyle and behavioral changes at each
visit.
Focused Search Question
The literature was searched for evidence to answer the clinical question in PIO format:
Does provider and patient education (P) improve the utilization of a cardiovascular risk
assessment tool and noninvasive screening test (I) in adult patients in the primary care setting
(O)?
Evidence Search
External Evidence. Five articles were reviewed focusing on CVD risks and screening.
Refer to Appendix B for Evidence Review Table. The level of evidence for all studies was Level
II, IV, and V (refer to Table 1, Level of Evidence Table, in Appendix A). All five articles
examined cardiovascular risks and the utilization of a cardiovascular screening tools with three
of the five studies portraying an increase in the use of the tool. Improved health outcomes in
adult patients were seen in four of the five studies examined. A more in-depth review of these
outcomes will be stated in the evidence appraisal, summary, and recommendations section.
Internal Evidence. The American Heart Association (2019) states that lifestyle changes
and patient education may prevent up to 80% of CVDs. Risk assessment is a crucial step in the
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approach of primary prevention of CVD. The ACC/AHA clinical practice guidelines recommend
the use of risk assessment tools to aid in the decision-making process for primary prevention of
CVD (Lloyd-Jones et al., 2019). Providing education and preventative screening for patients at
risks for CVDs can decrease their risk of having a CVD in the future.
Evidence Appraisal, Summary, and Recommendations
A search of the following databases: CINAHL, Cochrane Database of Systematic
Reviews, and MEDLINE was conducted to complete this evidence review. Based on the
literature search, keywords searched were: cardiovascular screening tool, cardiovascular (CV)
disease, CV screening tool, primary care, patient outcomes, health outcomes, patient education,
and patient adherence. Limits/filters included English language, adults, and published between
2012-2020. Refer to Appendix A, Evidence Search, for a complete list of the search terms in
each database.
Five articles were reviewed focusing on CVD risks and screening (refer to Appendix B,
Evidence Review Table). The level of evidence for all studies were Level II, IV, and V (refer to
Table 3 in Appendix C). Risk factors for cardiovascular disease were assessed in all five studies.
Four studies Collins et al. (2017), Byrne et al. (2020), Mallaina et al. (2013), and Fatema et al.
(2016) found health outcomes, including patient satisfaction, improved in adult patients who had
their cardiovascular risk factors assessed and screened. Additionally, a study by Collins and
colleagues (2017), provides support that the use of cardiovascular risk assessments can lead to
reductions in CVD morbidity and mortality. Lastly, a study by Byrne and colleagues (2020),
showed that patients understand their risk factors for cardiovascular disease through educational
sessions via mixed media (e.g., written material and visual aids).
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Patients consider their healthcare providers the most reliable source of health-related
information. Patients will follow treatment plans when they trust their healthcare provider.
According to Bussell et al. (2017), it is important providers use simple language and take the
time to educate patients. Fostering the patient-provider relationship via good communication has
been shown to improve patient adherence to treatment.
In summary, this evidence review provides support that cardiovascular risk assessment
and noninvasive screening in the primary care setting will reduce morbidity and mortality from
cardiovascular diseases. Therefore, providing continuing education and reminders to providers
about the “Pulse4Pulse” screening test and fostering the provider-patient communication during
office visits will improve the utilization of the “Pulse4Pulse” screening test in a primary care
office.
Project Plan
Project Goals
1. Increase provider and staff knowledge of the cardiovascular risk assessment and
screening tool and increase provider utilization of the “Pulse4Pulse” test.
2. Increase patient education through providing a brief explanation of the screening tool
upon patient’s filling out the form (See Appendix J).
3. Look at revenue earned, number of completed tests and number of referrals for
further workup before and after implementing the project.
Context
The primary care office where the project took place is located in Connecticut. The
practice is owned by a medical doctor and staff includes himself, one APRN as well as three
medical assistants, front desk staff and an office manager. The office is comprised of six total
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exam rooms. This primary care clinic acts as a principal point of healthcare services to patient
for all ages.
Project Team Members and Roles
Taylor Massey, RN, BSN, DNP candidate was the primary investigator (PI) of this QI
project. RoseAnna Petonito, APRN is the Practice Mentor who serves as the role model and
expert within the practice setting. Rosemary Johnson, DNP, APRN, ANP-BC is the DNP Project
Advisor who is the faculty member that provides expertise and guidance on implementing this
QI study.
Key Stakeholders
Key stakeholders included in the QI project included the medical doctor, RoseAnna
Petonito, DNP-FNP, the patients and staff. The “Pulse4Pulse” medical technician played a vital
role in the project; she was the one who provided the data from month to month in terms of how
many patients were eligible as well as who completed the test. She also provided the PI with the
yielded revenue for each month. The medical assistants (MA) had the role of placing the patients
in their designated exam rooms. If the patients were eligible for the test, the MAs were the
individuals who gave the patients the “Pulse4Pulse” questionnaire with the explanation attached.
Everyone played a vital role in the success of this quality improvement project. With the
dedication from each team member, the implementation of this QI project was made possible.
Possible Barriers to Implementation
Lack of time may be a barrier for primary care providers as well as lack of patient
involvement and compliance with partaking in “Pulse4Pulse” screening. Another barrier is
insurance not covering the test for the patient as well as lack of support from the staff (Pandhi et

13
al., 2020). It is important to continue to educate providers on the importance of utilizing this
screening tool to decrease future CVD.
Project Design and Methodology
Framework
The framework used for this quality improvement project was the Plan-Do-Study-Act
(PDSA) Cycle (IHI, 2020). This model is a four-stage problem-solving model used to improve a
process or carry out a change and is commonly used for QI projects. (Institute for Healthcare
Improvement, 2021). The four steps in the PDSA Cycle are:
Step 1. Plan
The PI will increase the utilization of a cardiovascular risk assessment tool in a primary
care setting through education
The goal is to see a 10% increase in the completion of the “Pulse4Pulse” test each month.
Steps to execute:
1. Measure the number of patients who were eligible for the “Pulse4Pulse” screening
and got the test completed 3 months prior to the process change
2. Measure the number of patients who had the “Pulse4Pulse” screening test completed
3 months after the process change
3. Compare revenue yield 3 months prior and after practice change
4. Compare number of referrals 3 months prior and after practice change
Step 2. Do:
▪

Through the educational session, providers were able to recognize the importance of
having their patients complete the cardiovascular risk assessment tool
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▪

With the implementation of a small explanation attached to each questionnaire, more
patients were inclined to filling it out and having the test completed

▪

More referrals were made as a result of more patients getting the test completed

Step 3. Study:
▪

The goal was to see a 10% increase or higher in the number of tests that were completed
each month.

▪

Total number of referrals and revenue increased each month

Step 4. Act:
▪

Including explanations for patients on screening tools allows them to better understand
what will be done

▪

The providers had enough time to explain the process to each patient as the patient had
already read the explanation on the questionnaire prior to seeing the provider

▪

Offering educational sessions can be beneficial to the providers

Sustainment
In order to reach sustainability, quality improvement initiatives must become the new
way of working. Reaching sustainability is not always an easy process and it takes a team of
individuals to implement the needed change. For the “Pulse4Pulse” screening tool to be
sustained at the primary care office, continued education for staff is crucial and should be done
every couple of months. Unfortunately, without the PI being at the office, there is a question if
screening patients is priority for the staff. Project method and results will be disseminated to the
primary care office so they can see how the increase in completed tests lead to an increase in
revenue and referrals to specialty care. Ideally, this method to improve utilization of the
“Pulse4Pulse” screening test will continue in order to prevent future CVD.
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Dissemination
The primary goal of disseminating evidence is to increase the motivation and ability to
use and apply the evidence upon completion of the QI project. There are different ways to
disseminate results, such as sending an e-mail, presenting a poster, completing a presentation,
posting charts, hand-outs, etc. To disseminate the results for this QI project, a poster will be
provided with an abstract as well as all data portrayed in tables and figures. The DNP candidate
will present the poster on April 22, 2022 to peers and professors. The DNP candidate will present
the final project to the primary care office where the project was completed and, lastly, the DNP
student will submit their final project paper to the digital repository for Sacred Heart University
in May 2022. The PI also plans to present findings at a professional nursing conference such as
the International Conference on Nursing Practice, Quality and Performance.
Timeline
A timeline for this project came be found in (Appendix B).
Resources
1. People:
a. Preceptor, patients, providers and office staff.
2. Material
a. The Pulse4Pulse questionnaire is of no cost as these are usually distributed to
patients daily. A 2x5 piece of paper is stapled to each Pulse4Pulse questionnaire
and provided by the PI.
Review for Ethical Consideration
This project involves educating providers and office staff on the utilization of a screening
tool. No patient names were observed. The completed quality improvement tool is portrayed in
(Form 1 in Appendix G). The results of this tool portrays that this project meets criteria for a
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quality improvement project. This project did not require Sacred Heart University Institutional
Review Board approval or to the review board of the primary care office.
Implementation, Evaluation, ROI, Outcome, Results
Project Implementation
In August of 2021, clinical staff knowledge of cardiovascular risk factors as well as their
views toward the current screening tool and utilization was assessed. A pretest questionnaire was
distributed one week prior to the educational review. Upon the completion of the educational
review, a post questionnaire was given directly following a 20-minute PowerPoint presentation.
The PI attached a small overview of the “Pulse4Pulse” screening test on each questionnaire for
the patient to better understand the test. Data was collected for the previous three months prior to
the practice change. Date collected included patients eligible for the “Pulse4Pulse” test,
completed “Pulse4Pulse” tests, total number of referrals generated from the tests, and revenue
yielded for each month. Data was displayed in an excel spreadsheet.
From September 2021 to December 2021, patients in the primary care office who were
eligible to receive the “Pulse4Pulse” test were given the questionnaire. Each month the number
of patients eligible for the “Pulse4Pulse” test was recorded as well as completed tests, total
number of referrals, total revenue yielded, and the number of referrals to specialists. The data
was collected and obtained from the “Pulse4Pulse” medical technician in the office. All data was
kept confidential portraying no patient names.
Data Collection
Once a week the PI met with the “Pulse4Pulse” technician who gave the number of
completed test and revenue yield from the test that week. The PI met with the other members in
the office at the end of each month to speak about their thoughts on how the project was going.
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The PI encouraged them to voice their opinions and any needed changes they thought would be
beneficial.
Data was collected through a chart provided to the PI by the “Pulse4Pulse” technician for
the three months prior to project implementation. September 2021-December 2021 was when the
implementation process began and data was collected for each month. Patients who were eligible
to receive the test were given a questionnaire and a brief description of the test. Those patients
who completed the “Pulse4Pulse” test as well as the number of referrals generated for each
completed test was documented. Lastly, the revenue yield was recorded as well for each test
completed. This process was repeated for all three months of the study.
Evaluation
Measure and Analysis
The recording and analysis of data was completed with Microsoft Excel. Prior to the
educational presentation provided, providers and staff were asked to complete a pre-test made by
the PI. Pre and post test scores using mean (M) and standard deviation (SD) was reported as well
as a line graph portraying the percent increase of completed “Pulse4Pulse” tests from month to
month (e.g., month 1 to 2, month 2 to 3, month 3 to 4, month 4 to 5, and month 5 to 6). Three
months post-intervention resulted in greater than a 10% increase in the first month, which was
the overall goal of the QI project (refer to Figure 3 in Appendix L).
Outcome Measurements
Prior to implementing the project, a survey was given out to the providers gauging their
current thoughts on the screening tool. There were a total of five questions to answer (See
Appendix E). Results of the survey concluded that the providers at this primary care office saw
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the tool as beneficial for patients but recognized that they themselves were not utilizing the tool
as much as they should be.
Data was collected on the three previous months. Data collected included the number of
patients who met eligibility for the “Pulse4Pulse” test, the number of patients who completed the
test, the total number of referrals and revenue yielded. Utilization of the “Pulse4Pulse” test was
not completed very often prior to implementation/intervention, as portrayed in Table 1 (refer to
Table 6 in Appendix N). Month 1 to 2 portrayed a -2% decrease in completed “Pulse4Pulse”
screening test, while month 2 to 3 portrayed a -3% decrease. Refer to Table 2 for a detailed look
at month-to-month calculations and results in Appendix N.
Prior to the educational presentation for clinical staff, staff were asked to complete a pretest made by the primary investigator. Average scores ranged from 70-100%. Directly following
the educational presentation, the same staff completed the post-test, with scores ranging from 90100%. The educational presentation was beneficial to staff because the average score from the
pre-test was 80% (14.1) and the post-test average score was 95% (5.8).
Utilization of the “Pulse4Pulse” test increased post-intervention. The largest increase
occurred between month 3 to 4 with a 14% increase which met project goal of a 10% monthly
increase. However, the last 2 months (i.e., months 5 and 6) of the study did not quite achieve the
goal of 10%. The percent increase for these months were 7% for each (Refer to Table 2 in
Appendix K).
In summary, the findings of this study showed the intervention to improve provider and
patient utilization was effective in increasing overall completion rates of the screening test. For
example, the percentage of completion in month 1 was 30%. In month 2, it dropped to 28%; it
dropped further in month 3 to 25%. After the intervention, completion rate for the “Pulse4Pulse”
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test was 40% in month 4, 46% in month 5, and 53% in month 6. Because more patients
completed the “Pulse4Pulse” screening test, as predicted the number of referrals to specialty care
such as vascular, cardiology and endocrinology, also increased. For example (refer to Table 5 in
Appendix M), in month 1 there was a total 4 referrals. For months 2 and 3, there were total of 2
and 3 referrals, respectively. In the three months after implementation of the study, the referral
rate increased to 12, 18, and 15 for months 4, 5, and 6, respectively. Revenue yield each month
increased as well, with month 4 totaling $4,800, month 5 portraying a $6,560, and month 6 with
a yield revenue of $6,880. For detailed explanation of the study findings, please refer to Table 5
in Appendix M.
Barriers Encountered During Implementation
As it is shown in the results, lack of time was not so much an issue in the first month of
the QI project. Month four showed great improvement in the number of tests done as well as the
number of the referrals sent. Potential barriers to the decrease in the last two months of the
implementation phase could possibly have been due to the providers taking their vacations. This
resulted in only one provider in the office during this period of the study. Unfortunately, it led to
an extremely booked schedule; therefore, the one provider may not have had enough time to talk
to patients about the screening tool.
The impact of COVID-19 was a barrier as well. While the clinic was back to seeing
patients in the office, there was an option for patients to complete their exams over telehealth,
especially during the first two months (i.e., months 4 and 5) of the project implementation. Due
to this possibility, overall “Pulse4Pulse” screening/completion could have been higher if those
patients, who were seen on telehealth, came into the office. If a patient does not come into the
office to be seen, they will not receive a questionnaire or be offered the “Pulse4Pulse” test.
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In month six, one of the medical assistants left the practice. Therefore, this only allowed
one MA to room patients. As a result, this may have caused the MA to forget to hand the patient
the questionnaire and educational print-out, or the MA was too busy to do so.
Lastly, another barrier was that even though a patient may qualify to receive the test
based on their risk factors, not all insurance will cover the test for the patient. This ultimately
could result in the patient having to choose either not get the test done or to pay out of pocket.
Return on Investment
The total project timeline was eight months: from April 2021 to December 2021. The
target goal of a 10% increase each month was met for the first month but not the second or third.
The “Pulse4Pulse” screening test continues to be utilized in the primary care office with the
emphasis on receiving the test through provider education to the patient. At this time the target
outcome goal of a 10% increase from month to month was met for only the first month. The
project achieved an overall increase in utilization of the “Pulse4Pulse” screening test by the
providers and completions for eligible patients by the end of the study. No additional resources
were required in terms of capital and there was a positive return on investment.
Dissemination
Implications of Project Results to Organization and Practice Community
Implementing education using a presentation and pre and post tests did prove that there
was an increase in the utilization of the “Pulse4Pulse” screening test. The primary care office
was utilizing this tool before implementation of the project, but screening tests were not always
performed for patients who were eligible. Attaching a 2x5 inch piece of paper to each
questionnaire was helpful in that the patients had an idea of what this test was, which ultimately
did not cause the providers to take more time during each appointment to explain it. While the
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work days can get very busy, the providers truly did make an effort to increase the amount of
tests to be completed. With the continued implementation of this project in the primary care
office, risk factors and potential future cardiovascular disease can be avoided with the utilization
of the “Pulse4Pulse” screening test.
Key Lessons Learned
Implementing change must build practice capacity and culture. For change to occur, it
needs to be supported by providers and office staff. It takes communication and building a
common goal among team members to effect positive change. There is always an opportunity to
improve one’s knowledge and education, and it does not matter what role you are in. In short,
utilizing the IHI (Institute for Healthcare Improvement, 2021) Model of Improvement provided a
method for a successfully implementation of a practice change in a healthcare setting (Taylor et
al., 2014).
The original goal before implementation was to see a 10% increase in the number of
“Pulse4Pulse” screening tests completed from month to month. It may have been better to set a
goal of 5% instead of the 10% that was chosen. This PI learned that change takes time and
sometimes that means not starting off with such a high goal. Additionally, the PI did not consider
the effects of losing or the reduction of clinical staff would have on patients completing the
“Pulse4Pulse” screening test. In summary, setting an achievable goal can influence performance
and facilitate the needed change (Aghera et al., 2018).
Sustainability Plan
In conclusion, to achieve sustainability, quality improvement initiatives must become the
new way of working. Reaching sustainability is not always an easy process and it takes a team of
individuals to implement the needed change (Silver et al., 2016). For the “Pulse4Pulse”
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screening tool to be sustained at the primary care office, continued education for staff is crucial
and should be done every couple of months. The planning and process for this project and the
results will be disseminated to the primary care office and other members of the team. Sharing
this information allow them to see the increase in completed tests and the number of referrals
generated to specialist as a result. Knowing the value of the “Pulse4Pulse” screening test,
through the revenue yield and number of specialty referrals, should be an incentive to keep the
clinical staff motivated to maintain and improve the utilization of the “Pulse4Pulse” screening
test to prevent future CVD.
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Table 1. Level of Evidence Synthesis
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Table 2. Evidence Synthesis
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Appendix D
Figure 1. Concept Map
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Appendix E

“Pulse4Pulse” Provider Survey
1. Do you provide education on the Pulse4Pulse tool?
• Yes
• No
• Maybe

2. Do you feel that providing more education about the tool would lead to more utilization
of the tool in the office?
• Yes
• No
• Maybe

3. Would a brief overview of the tool attached to the questionnaire help you with time and
giving less explanation to the patient?
• Yes
• No
• Maybe

4. Do you feel like lack of time with the patient leads to the test not being done?
• Yes
• No
• Sometimes

5. Do you encourage patients to make follow-up appointments to get Pulse4Pulse if they
refuse during their appointment?
• Yes
• No
• Sometimes
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Table 4. Project Timeline

Component

Doctor of Nursing Practice Project Roadmap

Person Responsible:
T.Massey

Definition

Date Done

Phase 1: Problem Identification and Evidence Review
Clinical Inquiry
including
background and
significance of
problem

Described the local problem of Pulse4Pulse not being
implemented enough in the PCP office. Data was obtained
from previous 3 months to show the need for this QI
project

1/29/21

Organizational
priority

Summarize information that supports topic/problem is an
organizational priority.

1/29/21

Searchable Question

Focused PIO question was written using evidence
searched from the literature.

1/29/21

External evidence

2/13/21

Evidence search

Modified on 2/14/21

Summarize search strategy (e.g. databases, keywords,
filters/limits, criteria for article selection, tools for critical
appraisal). Include practice-based evidence (e.g. evidencebased solutions that experts/other health systems have
implemented to address practice problem).
Internal evidence
•

Evidence appraisal,
summary, and
recommendations

2/13/21

Summarize applicable
unit/community/department/hospital/organizational
level data or data required for national entities (e.g.
CMS, NDNQI, AHRQ).

Perform needs assessment if applicable.

N/A

Organize evidence that answers focused clinical question
in a clear concise format (e.g. table or matrix).

2/11/21

Appraise literature for quality and applicability of
evidence using established method (e.g. Johns Hopkins
Nursing EBP Research Evidence Appraisal Tool, Joanna
Briggs Institute Critical Appraisal Tools, Fuld Institute for
EBP critical appraisal tools etc.).

2/13/21
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State recommendations(s) and link to evidence strength
and quality and risk/benefits.
Phase 2: Project Planning
Project goals

State intended, realistic outcomes of project using
established method (e.g. SMART criteria).

2/20/21

Framework

Select framework/model to guide implementation (e.g.
EBP model, QI framework, Change model).

2/20/21

Context

Describe project setting and participants or population, or
other elements that are central to where the change will
occur.

2/20/21

Key stakeholders

Identify agencies, departments, units, individuals needed
to complete the project and/or affected by project, and
strategies to gain buy-in.

2/24/21

Practice
change/intervention

Provided detailed description of practice change or
intervention (e.g. new or revised policy).

2/24/21

Evaluation

Summarize plan for evaluating the effectiveness of the
practice change. Identify applicable process and outcome
data to be collected/tracked and tools to do this. Identify
the methods for analyzing/interpreting the data (e.g.
control, run or Pareto charts).

2/24/21

Possible barriers to
implementation

Identify possible barriers and implementation strategies to
mitigate these barriers.

3/19/21

Sustainment

Identify strategies to sustain the change.

3/19/21

Timeline

Create a realistic timeline for project completion.

3/19/21

Resources

Identify all resources (e.g. indirect and direct) needed to
complete the project.

3/19/21

Ethical merit

Identify and obtain the required review and approval
needed for implementation (e.g. institution, community
agency, IRB).

3/19/21

Phase 3: Implementation
Implement project

Carry out the project using selected implementation
framework/model.

9/13/21

Track any deviations/changes from the project plan.

10/13/21
Complete by 12/13/21

Phase 4: Evaluation

38
Results/Interpretation Using an established method (e.g. run or control charts)
display data and interpret project outcomes.

12/30/21

Report evaluation of the effectiveness of the practice
change, including extent the practice change was
implemented (process outcome) and extent to which the
desired outcome(s) were achieved.

12/30/21

Return on investment Identify the final resources that were used to implement
the project. Calculate and report the return on investment.

Complete by 2/07/22

Phase 5: Dissemination
Traditional

Disseminate to the project setting in a manner meaningful
to them (e.g. executive report, poster, presentation at a
meeting, poster with QR code to access details of project,
etc.)
Disseminate in the format required by the academic
institution (e.g. poster, public presentation) and
Prepare final project write-up using established reporting
guidelines (e.g. EPQA, SQUIRE) and academic institution
requirements.

Complete by 4/13/22
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Appendix G
Form 1. Ethical Merit
Differentiating Quality Improvement and Research Activities Tool
Question
1.

Yes
Is the project designed to bring about immediate improvement in patient X
care?

2.

Is the purpose of the project to bring new knowledge to daily practice?

X

3.

Is the project designed to sustain the improvement?

X

4.

No

Is the purpose to measure the effect of a process change on delivery of X
care?

5.

Are ﬁndings specific to this hospital/setting?

X

6.

Are all patients who participate in the project expected to benefit?

X

7.

Is the intervention at least as safe as routine care?

X

8.

Will all participants receive at least usual care?

X

9.

Do you intend to gather just enough data to learn and complete the cycle? X

10.

Do you intend to limit the time for data collection in order to accelerate X
the rate of improvement?

11.

Is the project intended to test a novel hypothesis or replicate one?

X

12.

Does the project involve withholding any usual care?

X

13.

Does the project involve testing interventions/practices that are not usual
or standard of care?

X

14.

Will any of the 18 identifiers according to the HIPAA Privacy Rule be
included?

X

Note. Adapted from Foster, J. (2013). Differentiating quality improvement and research
activities. Clinical Nurse Specialist, 27(1), 10–3.
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Cardiovascular Disease Quiz
Please complete this brief quiz that assesses your current knowledge about cardiovascular
disease
1. Which is a cause of heart disease?
a. Arthritis
b. Stroke
c. Thickening of the inside of the arteries
d. None of the above
2. Which of these three risk factors cannot be controlled?
a. Medication use, drug use, smoking
b. Medication use, diet, alcoholism
c. None of the above
d. Age, gender, ethnicity
3. What is considered high blood pressure? (Select all that apply)
a. 92/76
b. 140/82
c. 160/80
d. 100/78
4. What can happen if blood flow in an artery is blocked or restricted?
a. Stroke
b. Heart attack
c. Itchiness
d. A & B
5. Which of these symptoms is a “classic symptom” of a heart attack?
a. Difficulty breathing
b. Pain that radiates from the chest to the neck, shoulders, jaw or arms
c. Crushing pain in the chest
d. Indigestion or heartburn
6. In the U.S., 1 in every 4 deaths is caused by heart disease.
a. True
b. False
7. The most common type of heart disease in the U.S. is:
a. Mitral valve prolapse
b. Arrhythmias
c. Coronary artery disease
d. Atrial fibrillation
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8. What is a borderline high level for total cholesterol?
a. 140 mg/dL
b. 180 mg/dL
c. 200 mg/dL
d. 250 mg/dL
9. What are the main tests used to identify asymptomatic diseases that Pulse 4 Pulse testes
for?
a. Sudomotor Test
b. Autonomic Nervous System Test
c. Ankle-Brachial Index Test
d. All of the above
10. Does this test offer reimbursement for the office?
a. Yes
b. No
c. Not sure
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Appendix I
Pulse4Pulse Questionnaire
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Appendix J

Explanation of “Pulse4Pulse” for Patients
The “Pulse4Pulse” is a test that will help your provider and you know what your possible
risk for having a heart attack, stroke, or bad blood flow to your legs and feet in the future.
Having these health issues can have a negative influence on your life and cause detrimental
health outcomes. If you answered “yes” to any of these questions, you should have this test
completed. This test can be done here in the office and only takes 15 minutes. This test will not
cause you any harm. The test consists of having your blood pressure checked and having stickers
placed on your arms, legs, and feet. Once you complete the test, you will get a phone call from
your provider in 3-7 days to go over your results. If you have any questions, you can discuss
them with your provider during your health visit today.
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Appendix K
Figure 2. Cardiovascular Pre/Post Test Results
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Appendix L
Figure 3. Month to Month Increase
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Appendix M
Table 5. Month to Month Results
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Table 6. Calculations and Results
Total Eligible

Total Completion Month Calculation to
obtain % of
completion

% of completion Month Calculation
to
to obtain
Month change in
month-tomonth
completion rate
30
1 to 2
28-30=

Month-to
month
completion
rate in %

60

18

1

18/60=

-2%

75

21

2

21/75=

28

2 to 3

25-28=

-3%

68

17

3

71/68=

25

3 to 4

40-25=

14%

77

30

4

30/77=

39

4 to 5

46-40=

7%

82

38

5

38/82=

46

5 to 6

53-46=

7%

80

43

6

43/80=

53
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Appendix O
Figure 4. Poster Presentation

